All In MedTech

PMA device

WATCHMAN FLX Pro Left Atrial Appendage Closure Device with Delivery System

Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

4

PMA pathway

Device trials

8

Naming "WATCHMAN FLX Pro"

MAUDE reports

3,161

Brand "WATCHMAN FLX Pro", since 2015

PubMed studies

30

Mentioning "WATCHMAN FLX Pro"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing WATCHMAN FLX Pro Left Atrial Appendage Closure Device with Delivery System

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 4 of 4 decisions filed under this name.

1 more FDA decisions with a free account

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

Clinical trials

Device studies on ClinicalTrials.gov that name "WATCHMAN FLX Pro", any status and sponsor, newest update first.

Open in Trial Radar
  • Prince of Wales Hospital, Shatin, Hong KongAcademic, hospital or other

    NCT05560204 · 200 participants (planned) · Start Jan 1, 2023 · Primary completion Dec 31, 2027

    Device: Combined Pulsed-field Ablation (PFA) + Left Atrial Appendage Occlusion (LAAO) · For: Combined Pulsed-field Ablation (PFA)

    Sites: Jordon, Hong Kong; Hong Kong, Hong Kong; Taipa, Macau

  • SIMPLAAFY Clinical TrialPivotal-lookingActive, not recruiting

    Boston Scientific CorporationPublic (BSX)

    NCT06521463 · 1,857 participants · Start Oct 1, 2024 · Primary completion Jul 7, 2026

    Device: WATCHMAN FLX Pro LAAC Device · For: Atrial Fibrillation; Stroke; Bleeding

    Sites: Birmingham, Alabama; Phoenix, Arizona; Scottsdale, Arizona · 86 sites in all

  • Boston Scientific CorporationPublic (BSX)

    NCT07349121 · 500 participants (planned) · Start Jun 18, 2026 · Primary completion Dec 2028

    Device: Concomitant pulsed field ablation (PFA) and left atrial appendage closure (LAAC) during one interventional case · For: Atrial Fibrillation (AF); Stroke Prevention in Patients With Atrial Fibrillation; Left Atrial Appendage Closure and 3 more

    Sites: Aalst, Belgium; Brussels, Belgium; Zagreb, Croatia · 11 sites in all

5 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "WATCHMAN FLX Pro", and for the whole product code for context.

This brand

3,161 reports: 80 malfunction, 2,747 injury, 334 death

Whole product code NGV

17,771 reports: 1,912 malfunction, 13,990 injury, 1,862 death

Newest reports for this brand

2 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

Published research

The most relevant PubMed records for "WATCHMAN FLX Pro"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

Other devices of this type

Also filed under product code NGV.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.